Clinical Trial Update: Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating combination chemotherapy for neurofibromatosis type 1 with progressive plexiform neurofibromas has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type
• Plexiform Neurofibroma

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Neurofibromatosis Type 1, Precancerous Condition | Phase 2 | Status: COMPLETED | Results posted: 2018-08-08